Dikranian A - Search Results

1

Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials.

Strand V, Lee EB, Yazici Y, Dikranian A, Wilkinson B, Takiya L, Zang C, Bananis E, Bergman MJ. Strand V, et al. Among authors: dikranian a. Clin Rheumatol. 2018 Aug;37(8):2043-2053. doi: 10.1007/s10067-018-4077-3. Epub 2018 Apr 14. Clin Rheumatol. 2018. PMID: 29656373 Free PMC article. Clinical Trial.

2

Model-Informed Development and Registration of a Once-Daily Regimen of Extended-Release Tofacitinib.

Lamba M, Hutmacher MM, Furst DE, Dikranian A, Dowty ME, Conrado D, Stock T, Nduaka C, Cook J, Krishnaswami S. Lamba M, et al. Among authors: dikranian a. Clin Pharmacol Ther. 2017 Jun;101(6):745-753. doi: 10.1002/cpt.576. Epub 2017 Feb 9. Clin Pharmacol Ther. 2017. PMID: 27859030 Free PMC article.

3

Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study.

Dikranian AH, Mallay R, Marshall M, Francis-Sedlak M, Holt RJ. Dikranian AH, et al. Rheumatol Ther. 2017 Dec;4(2):363-374. doi: 10.1007/s40744-017-0075-1. Epub 2017 Aug 17. Rheumatol Ther. 2017. PMID: 28819927 Free PMC article.

4

Comparison of patient and physician perspectives in the management of rheumatoid arthritis: results from global physician- and patient-based surveys.

Gibofsky A, Galloway J, Kekow J, Zerbini C, de la Vega M, Lee G, Lee EY, Codreanu C, Koehn C, Steinberg K, Bananis E, de Leon DP, Maniccia A, Dikranian A; RA NarRAtive global advisory panel. Gibofsky A, et al. Among authors: dikranian a. Health Qual Life Outcomes. 2018 Nov 9;16(1):211. doi: 10.1186/s12955-018-1035-3. Health Qual Life Outcomes. 2018. PMID: 30413162 Free PMC article.

5

Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe.

Gottlieb A, Gratacos J, Dikranian A, van Tubergen A, Fallon L, Emir B, Aikman L, Smith T, Chen L. Gottlieb A, et al. Among authors: dikranian a. Rheumatol Int. 2019 Jan;39(1):121-130. doi: 10.1007/s00296-018-4195-x. Epub 2018 Nov 13. Rheumatol Int. 2019. PMID: 30426237 Free PMC article.

6

Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib.

Dikranian A, Gold D, Bessette L, Nash P, Azevedo VF, Wang L, Woolcott J, Shapiro AB, Szumski A, Fleishaker D, Wollenhaupt J. Dikranian A, et al. Rheumatol Ther. 2022 Apr;9(2):411-433. doi: 10.1007/s40744-021-00405-w. Epub 2021 Dec 17. Rheumatol Ther. 2022. PMID: 34921355 Free PMC article.

7

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.

Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.

8

Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies.

Dikranian AH, Gonzalez-Gay MA, Wellborne F, Álvaro-Gracia JM, Takiya L, Stockert L, Paulissen J, Shi H, Tatulych S, Curtis JR. Dikranian AH, et al. RMD Open. 2022 May;8(1):e002103. doi: 10.1136/rmdopen-2021-002103. RMD Open. 2022. PMID: 35577477 Free PMC article. Clinical Trial.

9

A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis.

Baker MC, Kavanagh S, Cohen S, Matsumoto AK, Dikranian A, Tesser J, Kivitz A, Alataris K, Genovese MC. Baker MC, et al. Among authors: dikranian a. Arthritis Rheumatol. 2023 Dec;75(12):2107-2115. doi: 10.1002/art.42637. Epub 2023 Nov 9. Arthritis Rheumatol. 2023. PMID: 37390360 Clinical Trial.

10

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.

Gabay C, Emery P, van Vollenhoven R, Dikranian A, Alten R, Pavelka K, Klearman M, Musselman D, Agarwal S, Green J, Kavanaugh A; ADACTA Study Investigators. Gabay C, et al. Among authors: dikranian a. Lancet. 2013 May 4;381(9877):1541-50. doi: 10.1016/S0140-6736(13)60250-0. Epub 2013 Mar 18. Lancet. 2013. PMID: 23515142 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page